Realigned from parent company Stellantis’ premium division to entry-level in 2023, Citroën’s fortunes have dramatically changed over the last three years. With product sourcing originating in India ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Google DeepMind is opening up access to Project Genie, its AI tool for creating interactive game worlds from text prompts or images. Starting Thursday, Google AI Ultra subscribers in the U.S. can play ...

Gloria Kaasch-Buerger’s first seven weeks in her role as Basalt town manager have been both a whirlwind and a respite from the usual workload of local government. “The holidays is an interesting time ...

A WIRED review of outputs hosted on Grok’s official website shows it’s being used to create violent sexual images and videos, as well as content that includes apparent minors. Unlike on X, where ...